Skip to main content
Top
Published in: Diabetologia 7/2012

01-07-2012 | Article

Early seroconversion and rapidly increasing autoantibody concentrations predict prepubertal manifestation of type 1 diabetes in children at genetic risk

Authors: V. Parikka, K. Näntö-Salonen, M. Saarinen, T. Simell, J. Ilonen, H. Hyöty, R. Veijola, M. Knip, O. Simell

Published in: Diabetologia | Issue 7/2012

Login to get access

Abstract

Aims/hypothesis

The aim of the study was to investigate the timing of the appearance of autoantibodies associated with type 1 diabetes between birth and puberty, the natural fate of these autoantibodies and the predictive power of autoantibody concentrations for early progression to clinical diabetes.

Methods

Children were recruited to the Type 1 Diabetes Prediction and Prevention Project, an ongoing study based on HLA-conferred genetic risk. Autoantibodies against islet cells, insulin, GAD65 and islet antigen 2 were analysed at 3–12 month intervals, starting from birth.

Results

During the follow-up, 1,320 children (18.4% of the cohort of 7,165 children) were autoantibody positive in at least one sample. Altogether, 184 autoantibody-positive children progressed to type 1 diabetes. Seroconversion occurred at an early age in the progressors (median 1.5 years), among whom 118 (64%) and 150 (82%) seroconverted to autoantibody positivity before the age of 2 and 3 years, respectively. The incidence of seroconversion peaked at 1 year of age. Compared with other autoantibody-positive children, the median autoantibody levels were already markedly higher 3 to 6 months after the seroconversion in children who later progressed to diabetes.

Conclusions/interpretation

Early initiation of autoimmunity and rapid increases in autoantibody titres strongly predict progression to overt diabetes before puberty, emphasising the importance of early life events in the development of type 1 diabetes.
Appendix
Available only for authorised users
Literature
1.
go back to reference Onkamo P, Väänänen S, Karvonen M, Tuomilehto J (1999) Worldwide increase in incidence of type I diabetes—the analysis of the data on published incidence trends. Diabetologia 42:1395–1403PubMedCrossRef Onkamo P, Väänänen S, Karvonen M, Tuomilehto J (1999) Worldwide increase in incidence of type I diabetes—the analysis of the data on published incidence trends. Diabetologia 42:1395–1403PubMedCrossRef
2.
go back to reference DIAMOND Project Group (2006) Incidence and trends of childhood type 1 diabetes worldwide 1990–1999. Diabet Med 23:857–866CrossRef DIAMOND Project Group (2006) Incidence and trends of childhood type 1 diabetes worldwide 1990–1999. Diabet Med 23:857–866CrossRef
3.
go back to reference Patterson CC, Dahlquist GG, Gyürüs E, Green A, Soltész G, EURODIAB Study Group (2009) Incidence trends for childhood type 1 diabetes in Europe during 1989–2003 and predicted new cases 2005–2020: a multicentre prospective registration study. Lancet 373:2027–2033PubMedCrossRef Patterson CC, Dahlquist GG, Gyürüs E, Green A, Soltész G, EURODIAB Study Group (2009) Incidence trends for childhood type 1 diabetes in Europe during 1989–2003 and predicted new cases 2005–2020: a multicentre prospective registration study. Lancet 373:2027–2033PubMedCrossRef
4.
go back to reference Pitkäniemi J, Onkamo P, Tuomilehto J, Arjas E (2004) Increasing incidence of type 1 diabetes—role for genes? BMC Genet 5:5PubMedCrossRef Pitkäniemi J, Onkamo P, Tuomilehto J, Arjas E (2004) Increasing incidence of type 1 diabetes—role for genes? BMC Genet 5:5PubMedCrossRef
5.
go back to reference Harjutsalo V, Sjöberg L, Tuomilehto J (2008) Time trends in the incidence of type 1 diabetes in Finnish children: a cohort study. Lancet 371:1777–1782PubMedCrossRef Harjutsalo V, Sjöberg L, Tuomilehto J (2008) Time trends in the incidence of type 1 diabetes in Finnish children: a cohort study. Lancet 371:1777–1782PubMedCrossRef
6.
go back to reference Gardner SG, Bingley PJ, Sawtell PA, Weeks S, Gale EA (1997) Rising incidence of insulin dependent diabetes in children aged under 5 years in the Oxford region: time trend analysis. The Bart's-Oxford Study Group. BMJ 315:713–717PubMedCrossRef Gardner SG, Bingley PJ, Sawtell PA, Weeks S, Gale EA (1997) Rising incidence of insulin dependent diabetes in children aged under 5 years in the Oxford region: time trend analysis. The Bart's-Oxford Study Group. BMJ 315:713–717PubMedCrossRef
7.
go back to reference Todd JA (1995) Genetic analysis of type 1 diabetes using whole genome approaches. Proc Natl Acad Sci U S A 92:8560–8565PubMedCrossRef Todd JA (1995) Genetic analysis of type 1 diabetes using whole genome approaches. Proc Natl Acad Sci U S A 92:8560–8565PubMedCrossRef
8.
go back to reference Ilonen J, Sjöroos M, Knip M et al (2002) Estimation of genetic risk for type 1 diabetes. Am J Med Genet 115:30–36PubMedCrossRef Ilonen J, Sjöroos M, Knip M et al (2002) Estimation of genetic risk for type 1 diabetes. Am J Med Genet 115:30–36PubMedCrossRef
9.
go back to reference Gillespie KM, Bain SC, Barnett AH et al (2004) The rising incidence of childhood type 1 diabetes and reduced contribution of high-risk HLA haplotypes. Lancet 364:1699–1700PubMedCrossRef Gillespie KM, Bain SC, Barnett AH et al (2004) The rising incidence of childhood type 1 diabetes and reduced contribution of high-risk HLA haplotypes. Lancet 364:1699–1700PubMedCrossRef
10.
go back to reference Knip M, Veijola R, Virtanen SM, Hyöty H, Vaarala O, Åkerblom HK (2005) Environmental triggers and determinants of type 1 diabetes. Diabetes 54:S125–S136PubMedCrossRef Knip M, Veijola R, Virtanen SM, Hyöty H, Vaarala O, Åkerblom HK (2005) Environmental triggers and determinants of type 1 diabetes. Diabetes 54:S125–S136PubMedCrossRef
11.
go back to reference Oresic M, Simell S, Sysi-Aho M et al (2008) Dysregulation of lipid and amino acid metabolism precedes islet autoimmunity in children who later progress to type 1 diabetes. J Exp Med 205:2975–2984PubMedCrossRef Oresic M, Simell S, Sysi-Aho M et al (2008) Dysregulation of lipid and amino acid metabolism precedes islet autoimmunity in children who later progress to type 1 diabetes. J Exp Med 205:2975–2984PubMedCrossRef
12.
go back to reference Notkins AL, Lernmark A (2001) Autoimmune type 1 diabetes: resolved and unresolved issues. J Clin Invest 108:1247–1252PubMed Notkins AL, Lernmark A (2001) Autoimmune type 1 diabetes: resolved and unresolved issues. J Clin Invest 108:1247–1252PubMed
13.
go back to reference Siljander HT, Simell S, Hekkala A et al (2009) Predictive characteristics of diabetes-associated autoantibodies among children with HLA-conferred disease susceptibility in the general population. Diabetes 58:2835–2842PubMedCrossRef Siljander HT, Simell S, Hekkala A et al (2009) Predictive characteristics of diabetes-associated autoantibodies among children with HLA-conferred disease susceptibility in the general population. Diabetes 58:2835–2842PubMedCrossRef
14.
go back to reference Lambert AP, Gillespie KM, Thomson G et al (2004) Absolute risk of childhood-onset type 1 diabetes defined by human leukocyte antigen class II genotype: a population-based study in the United Kingdom. J Clin Endocrinol Metab 89:4037–4043PubMedCrossRef Lambert AP, Gillespie KM, Thomson G et al (2004) Absolute risk of childhood-onset type 1 diabetes defined by human leukocyte antigen class II genotype: a population-based study in the United Kingdom. J Clin Endocrinol Metab 89:4037–4043PubMedCrossRef
15.
go back to reference Kulmala P, Savola K, Petersen JS et al (1998) Prediction of insulin-dependent diabetes mellitus in siblings of children with diabetes. A population-based study. The Childhood Diabetes in Finland Study Group. J Clin Invest 101:327–336PubMedCrossRef Kulmala P, Savola K, Petersen JS et al (1998) Prediction of insulin-dependent diabetes mellitus in siblings of children with diabetes. A population-based study. The Childhood Diabetes in Finland Study Group. J Clin Invest 101:327–336PubMedCrossRef
16.
go back to reference Verge CF, Gianani R, Kawasaki E et al (1996) Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies. Diabetes 45:926–933PubMedCrossRef Verge CF, Gianani R, Kawasaki E et al (1996) Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies. Diabetes 45:926–933PubMedCrossRef
17.
go back to reference Bingley PJ, Christie MR, Bonifacio E et al (1994) Combined analysis of autoantibodies improves prediction of IDDM in islet cell antibody-positive relatives. Diabetes 43:1304–1310PubMedCrossRef Bingley PJ, Christie MR, Bonifacio E et al (1994) Combined analysis of autoantibodies improves prediction of IDDM in islet cell antibody-positive relatives. Diabetes 43:1304–1310PubMedCrossRef
18.
go back to reference Keskinen P, Korhonen S, Kupila A et al (2002) First-phase insulin response in young healthy children at genetic and immunological risk for type I diabetes. Diabetologia 45:1639–1648PubMedCrossRef Keskinen P, Korhonen S, Kupila A et al (2002) First-phase insulin response in young healthy children at genetic and immunological risk for type I diabetes. Diabetologia 45:1639–1648PubMedCrossRef
19.
go back to reference Sjöroos M, Iitiä A, Ilonen J, Reijonen H, Lövgren T (1995) Triple-label hybridization assay for type-1 diabetes-related HLA alleles. Biotechniques 18:870–877PubMed Sjöroos M, Iitiä A, Ilonen J, Reijonen H, Lövgren T (1995) Triple-label hybridization assay for type-1 diabetes-related HLA alleles. Biotechniques 18:870–877PubMed
20.
go back to reference Ilonen J, Reijonen H, Herva E et al (1996) Rapid HLA-DQB1 genotyping for four alleles in the assessment of risk for IDDM in the Finnish population. The Childhood Diabetes in Finland (DiMe) Study Group. Diabetes Care 19:795–800PubMedCrossRef Ilonen J, Reijonen H, Herva E et al (1996) Rapid HLA-DQB1 genotyping for four alleles in the assessment of risk for IDDM in the Finnish population. The Childhood Diabetes in Finland (DiMe) Study Group. Diabetes Care 19:795–800PubMedCrossRef
21.
go back to reference Nejentsev S, Sjöroos M, Soukka T et al (1999) Population-based genetic screening for the estimation of type 1 diabetes mellitus risk in Finland: selective genotyping of markers in the HLA-DQB1, HLA-DQA1 and HLA-DRB1 loci. Diabet Med 16:985–992PubMedCrossRef Nejentsev S, Sjöroos M, Soukka T et al (1999) Population-based genetic screening for the estimation of type 1 diabetes mellitus risk in Finland: selective genotyping of markers in the HLA-DQB1, HLA-DQA1 and HLA-DRB1 loci. Diabet Med 16:985–992PubMedCrossRef
22.
go back to reference Bottazzo GF, Florin-Christensen A, Doniach D (1974) Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet 2:1279–1283PubMedCrossRef Bottazzo GF, Florin-Christensen A, Doniach D (1974) Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet 2:1279–1283PubMedCrossRef
23.
go back to reference Savola K, Sabbah E, Kulmala P, Vähäsalo P, Ilonen J, Knip M (1998) Autoantibodies associated with type I diabetes mellitus persist after diagnosis in children. Diabetologia 41:1293–1297PubMedCrossRef Savola K, Sabbah E, Kulmala P, Vähäsalo P, Ilonen J, Knip M (1998) Autoantibodies associated with type I diabetes mellitus persist after diagnosis in children. Diabetologia 41:1293–1297PubMedCrossRef
24.
go back to reference Williams AJ, Bingley PJ, Bonifacio E, Palmer JP, Gale EA (1997) A novel micro-assay for insulin autoantibodies. J Autoimmun 10:473–478PubMedCrossRef Williams AJ, Bingley PJ, Bonifacio E, Palmer JP, Gale EA (1997) A novel micro-assay for insulin autoantibodies. J Autoimmun 10:473–478PubMedCrossRef
25.
go back to reference Ronkainen MS, Hämäläinen AM, Koskela P, Åkerblom HK, Knip M, Finnish Trigr Study Group (2001) Pregnancy induces nonimmunoglobulin insulin-binding activity in both maternal and cord blood serum. Clin Exp Immunol 124:190–196PubMedCrossRef Ronkainen MS, Hämäläinen AM, Koskela P, Åkerblom HK, Knip M, Finnish Trigr Study Group (2001) Pregnancy induces nonimmunoglobulin insulin-binding activity in both maternal and cord blood serum. Clin Exp Immunol 124:190–196PubMedCrossRef
26.
go back to reference Savola K, Bonifacio E, Sabbah E et al (1998) IA-2 antibodies—a sensitive marker of IDDM with clinical onset in childhood and adolescence. Childhood Diabetes in Finland Study Group. Diabetologia 41:424–429PubMedCrossRef Savola K, Bonifacio E, Sabbah E et al (1998) IA-2 antibodies—a sensitive marker of IDDM with clinical onset in childhood and adolescence. Childhood Diabetes in Finland Study Group. Diabetologia 41:424–429PubMedCrossRef
27.
go back to reference Näntö-Salonen K, Kupila A, Simell S et al (2008) Nasal insulin to prevent type 1 diabetes in children with HLA genotypes and autoantibodies conferring increased risk of disease: a double-blind, randomised controlled trial. Lancet 372:1746–1755PubMedCrossRef Näntö-Salonen K, Kupila A, Simell S et al (2008) Nasal insulin to prevent type 1 diabetes in children with HLA genotypes and autoantibodies conferring increased risk of disease: a double-blind, randomised controlled trial. Lancet 372:1746–1755PubMedCrossRef
28.
go back to reference Ziegler AG, Hummel M, Schenker M, Bonifacio E (1999) Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes: the 2-year analysis of the German BABYDIAB Study. Diabetes 48:460–468PubMedCrossRef Ziegler AG, Hummel M, Schenker M, Bonifacio E (1999) Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes: the 2-year analysis of the German BABYDIAB Study. Diabetes 48:460–468PubMedCrossRef
29.
go back to reference TEDDY Study Group (2008) The Environmental Determinants of Diabetes in the Young (TEDDY) study. Ann N Y Acad Sci 1150:1–13CrossRef TEDDY Study Group (2008) The Environmental Determinants of Diabetes in the Young (TEDDY) study. Ann N Y Acad Sci 1150:1–13CrossRef
30.
go back to reference Karvonen M, Pitkäniemi J, Tuomilehto J (1999) The onset age of type 1 diabetes in Finnish children has become younger. The Finnish Childhood Diabetes Registry Group. Diabetes Care 22:1066–1070PubMedCrossRef Karvonen M, Pitkäniemi J, Tuomilehto J (1999) The onset age of type 1 diabetes in Finnish children has become younger. The Finnish Childhood Diabetes Registry Group. Diabetes Care 22:1066–1070PubMedCrossRef
31.
go back to reference Knip M, Korhonen S, Kulmala P et al (2010) Prediction of type 1 diabetes in the general population. Diabetes Care 33:1206–1212PubMedCrossRef Knip M, Korhonen S, Kulmala P et al (2010) Prediction of type 1 diabetes in the general population. Diabetes Care 33:1206–1212PubMedCrossRef
32.
go back to reference Nejentsev S, Howson JM, Walker NM et al (2007) Localization of type 1 diabetes susceptibility to the MHC class I genes HLA-B and HLA-A. Nature 450:887–892PubMedCrossRef Nejentsev S, Howson JM, Walker NM et al (2007) Localization of type 1 diabetes susceptibility to the MHC class I genes HLA-B and HLA-A. Nature 450:887–892PubMedCrossRef
33.
go back to reference Lipponen K, Gombos Z, Kiviniemi M et al (2010) Effect of HLA class I and class II alleles on progression from autoantibody positivity to overt type 1 diabetes in children with risk-associated class II genotypes. Diabetes 59:3253–3256PubMedCrossRef Lipponen K, Gombos Z, Kiviniemi M et al (2010) Effect of HLA class I and class II alleles on progression from autoantibody positivity to overt type 1 diabetes in children with risk-associated class II genotypes. Diabetes 59:3253–3256PubMedCrossRef
34.
go back to reference Barrett JC, Clayton DG, Concannon P et al (2009) Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nat Genet 41:703–707PubMedCrossRef Barrett JC, Clayton DG, Concannon P et al (2009) Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nat Genet 41:703–707PubMedCrossRef
35.
go back to reference Bonifacio E, Bingley PJ, Shattock M et al (1990) Quantification of islet-cell antibodies and prediction of insulin-dependent diabetes. Lancet 335:147–149PubMedCrossRef Bonifacio E, Bingley PJ, Shattock M et al (1990) Quantification of islet-cell antibodies and prediction of insulin-dependent diabetes. Lancet 335:147–149PubMedCrossRef
36.
go back to reference Thivolet C, Beaufrère B, Geburher L, Chatelain P, Orgiazzi J, François R (1991) Autoantibodies and genetic factors associated with the development of type 1 (insulin-dependent) diabetes mellitus in first degree relatives of diabetic patients. Diabetologia 34:186–191PubMedCrossRef Thivolet C, Beaufrère B, Geburher L, Chatelain P, Orgiazzi J, François R (1991) Autoantibodies and genetic factors associated with the development of type 1 (insulin-dependent) diabetes mellitus in first degree relatives of diabetic patients. Diabetologia 34:186–191PubMedCrossRef
37.
go back to reference Achenbach P, Warncke K, Reiter J et al (2004) Stratification of type 1 diabetes risk on the basis of islet autoantibody characteristics. Diabetes 53:384–392PubMedCrossRef Achenbach P, Warncke K, Reiter J et al (2004) Stratification of type 1 diabetes risk on the basis of islet autoantibody characteristics. Diabetes 53:384–392PubMedCrossRef
38.
go back to reference Barker JM, Barriga KJ, Yu L et al (2004) Prediction of autoantibody positivity and progression to type 1 diabetes: Diabetes Autoimmunity Study in the Young (DAISY). J Clin Endocrinol Metab 89:3896–3902PubMedCrossRef Barker JM, Barriga KJ, Yu L et al (2004) Prediction of autoantibody positivity and progression to type 1 diabetes: Diabetes Autoimmunity Study in the Young (DAISY). J Clin Endocrinol Metab 89:3896–3902PubMedCrossRef
39.
go back to reference Sosenko JM, Skyler JS, Palmer JP et al (2011) A longitudinal study of GAD65 and ICA512 autoantibodies during the progression to type 1 diabetes in Diabetes Prevention Trial-type 1 (DPT-1) Participants. Diabetes Care 34:2435–2437PubMedCrossRef Sosenko JM, Skyler JS, Palmer JP et al (2011) A longitudinal study of GAD65 and ICA512 autoantibodies during the progression to type 1 diabetes in Diabetes Prevention Trial-type 1 (DPT-1) Participants. Diabetes Care 34:2435–2437PubMedCrossRef
40.
go back to reference Steck AK, Johnson K, Barriga KJ et al (2011) Age of islet autoantibody appearance and mean levels of insulin, but not GAD or IA-2 autoantibodies, predict age of diagnosis of type 1 diabetes: diabetes autoimmunity study in the young. Diabetes Care 34:1397–1399PubMedCrossRef Steck AK, Johnson K, Barriga KJ et al (2011) Age of islet autoantibody appearance and mean levels of insulin, but not GAD or IA-2 autoantibodies, predict age of diagnosis of type 1 diabetes: diabetes autoimmunity study in the young. Diabetes Care 34:1397–1399PubMedCrossRef
Metadata
Title
Early seroconversion and rapidly increasing autoantibody concentrations predict prepubertal manifestation of type 1 diabetes in children at genetic risk
Authors
V. Parikka
K. Näntö-Salonen
M. Saarinen
T. Simell
J. Ilonen
H. Hyöty
R. Veijola
M. Knip
O. Simell
Publication date
01-07-2012
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 7/2012
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-012-2523-3

Other articles of this Issue 7/2012

Diabetologia 7/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.